Literature DB >> 10964273

Salmonella enteritidis diarrhoea in Harare, Zimbabwe.

C Simango1, C Mbewe.   

Abstract

The study was conducted to determine the prevalence of Salmonella enteritidis diarrhoea in an urban area in Zimbabwe. Stool specimens from people of all ages presenting at primary level health centres in Harare were investigated for S. enteritidis and other bacterial and parasitic enteric pathogens. The first 46 S. enteritidis isolates were phage-typed, and all isolates were tested for susceptibility to ampicillin (10 microg), chloramphenicol (30 microg), cotrimoxazole (25 microg), tetracycline (30 microg), gentamicin (10 microg), nalidixic acid (30 microg), ciprofloxacin (5 microg) and ceftriaxone (30 microg). S. enteritidis was isolated in 74 (1.8%) of 4155 stool specimens which represented 30.7% of all Salmonella species isolated. The most common S. enteritidis phage type was 4 (78.3%) followed by 7, 9 and 23 (8.7%, 2.2%, 2.2%, respectively) All S. enteritidis isolates were sensitive to gentamicin, ciprofloxacin and ceftriaxone. Less than 10% of the isolates were resistant to the other antimicrobials except ampicillin, to which 13.5% were resistant. One isolate was resistant to ampicillin, chloramphenicol, cotrimoxazole and nalidixic acid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964273     DOI: 10.1046/j.1365-3156.2000.00587.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  2 in total

1.  An epidemiologic review of enteropathogens in Gaborone, Botswana: shifting patterns of resistance in an HIV endemic region.

Authors:  Jack S Rowe; Samir S Shah; Stephen Motlhagodi; Margaret Bafana; Ephraim Tawanana; Hong T Truong; Sarah M Wood; Nicola M Zetola; Andrew P Steenhoff
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

2.  Effect of Salmonella enteric Serovar Typhimurium in Pregnant Mice: A Biochemical and Histopathological Study.

Authors:  Geeta Shukla; Ishita Verma; Lalita Sharma
Journal:  Gastroenterology Res       Date:  2012-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.